Found: 92
Select item for more details and to access through your institution.
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 280, doi. 10.1111/bjh.19552
- By:
- Publication type:
- Article
Outcomes of pirtobrutinib for relapsed/refractory mantle cell lymphoma in compassionate use program in Europe.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 10, p. 1, doi. 10.1002/cam4.7289
- By:
- Publication type:
- Article
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1587, doi. 10.1007/s00277-023-05587-7
- By:
- Publication type:
- Article
PD‐L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD‐L1‐low and ‐negative patients with non‐small cell lung cancer.
- Published in:
- Journal of Extracellular Vesicles, 2024, v. 13, n. 3, p. 1, doi. 10.1002/jev2.12418
- By:
- Publication type:
- Article
Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis.
- Published in:
- EJHaem, 2024, v. 5, n. 1, p. 93, doi. 10.1002/jha2.827
- By:
- Publication type:
- Article
Involved-Site Radiation Therapy Enables Effective Disease Control in Parenchymal Low-Grade Primary Cerebral Lymphoma.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5564, doi. 10.3390/cancers15235564
- By:
- Publication type:
- Article
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 9, p. 2543, doi. 10.1007/s00277-023-05353-9
- By:
- Publication type:
- Article
Cost‐effectiveness of polatuzumab vedotin in combination with chemoimmunotherapy (pola‐R‐CHP) in previously untreated diffuse large B‐cell lymphoma in Germany.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 771, doi. 10.1111/bjh.18869
- By:
- Publication type:
- Article
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12056, doi. 10.3390/ijms241512056
- By:
- Publication type:
- Article
Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma—A Critical Toxicity Evaluation in the Modern Treatment Era.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2909, doi. 10.3390/cancers15112909
- By:
- Publication type:
- Article
Lack of reproducibility of histopathological features in MYC‐rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
- Published in:
- Histopathology, 2023, v. 82, n. 7, p. 1105, doi. 10.1111/his.14896
- By:
- Publication type:
- Article
Diffuse Large B-Cell Lymphoma and Related Entities: Diagnosis, Treatment, and Follow-Up.
- Published in:
- Deutsches Ärzteblatt International, 2023, v. 120, n. 17, p. 289, doi. 10.3238/arztebl.m2023.0035
- By:
- Publication type:
- Article
Radiomics of Tumor Heterogeneity in 18 F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2297, doi. 10.3390/cancers15082297
- By:
- Publication type:
- Article
Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2373, doi. 10.3390/cancers15082373
- By:
- Publication type:
- Article
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 4, p. 755, doi. 10.1007/s00277-023-05111-x
- By:
- Publication type:
- Article
Impact of intensified contact precautions while treating hematopoietic stem cell transplantation recipients during aplasia.
- Published in:
- European Journal of Medical Research, 2023, v. 28, n. 1, p. 1, doi. 10.1186/s40001-023-01085-8
- By:
- Publication type:
- Article
Liquid Biopsies in Lung Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1430, doi. 10.3390/cancers15051430
- By:
- Publication type:
- Article
Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 983, doi. 10.3390/cancers15030983
- By:
- Publication type:
- Article
The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists.
- Published in:
- Strahlentherapie und Onkologie, 2023, v. 199, n. 2, p. 115, doi. 10.1007/s00066-022-02035-9
- By:
- Publication type:
- Article
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 63, doi. 10.1007/s00277-022-05025-0
- By:
- Publication type:
- Article
Efficacy of COVID-19 Booster Vaccines in Patients with Hematologic Malignancies: Experiences in a Real-World Scenario.
- Published in:
- Cancers, 2022, v. 14, n. 22, p. 5512, doi. 10.3390/cancers14225512
- By:
- Publication type:
- Article
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphoma.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01110-1
- By:
- Publication type:
- Article
Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.903691
- By:
- Publication type:
- Article
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 482, doi. 10.1111/bjh.18161
- By:
- Publication type:
- Article
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.919278
- By:
- Publication type:
- Article
Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series.
- Published in:
- Current Oncology, 2022, v. 29, n. 4, p. 2312, doi. 10.3390/curroncol29040188
- By:
- Publication type:
- Article
Successful Treatment of Vaccine-Induced Immune Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 2, p. 210, doi. 10.1159/000519451
- By:
- Publication type:
- Article
Upstream open reading frames regulate translation of cancer-associated transcripts and encode HLA-presented immunogenic tumor antigens.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 3, p. 1, doi. 10.1007/s00018-022-04145-0
- By:
- Publication type:
- Article
Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.826342
- By:
- Publication type:
- Article
Dexamethasone‐mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 995, doi. 10.1111/bjh.17940
- By:
- Publication type:
- Article
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 766, doi. 10.3390/curroncol29020065
- By:
- Publication type:
- Article
Tumorzellspezifisches Targeting von Ibrutinib: Einführung von elektrostatischen Antikörper‐Inhibitor‐Konjugaten (AiCs).
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 1, p. 1, doi. 10.1002/ange.202109769
- By:
- Publication type:
- Article
Tumor‐Cell‐Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody‐Inhibitor Conjugates (AiCs).
- Published in:
- Angewandte Chemie International Edition, 2022, v. 61, n. 1, p. 1, doi. 10.1002/anie.202109769
- By:
- Publication type:
- Article
Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221103321
- By:
- Publication type:
- Article
Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5880, doi. 10.3390/cancers13235880
- By:
- Publication type:
- Article
The Burden of Survivorship on Hematological Patients—Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5640, doi. 10.3390/cancers13225640
- By:
- Publication type:
- Article
The role of autologous stem cell transplantation (ASCT) in aggressive B-cell lymphomas: real-world data from a retrospective single-center analysis.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 11, p. 2733, doi. 10.1007/s00277-021-04650-5
- By:
- Publication type:
- Article
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.757664
- By:
- Publication type:
- Article
Poster: ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01533-0
- By:
- Publication type:
- Article
ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S376, doi. 10.1016/S2152-2650(21)01860-7
- By:
- Publication type:
- Article
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 7, p. 1871, doi. 10.1007/s00277-020-04382-y
- By:
- Publication type:
- Article
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2917, doi. 10.3390/cancers13122917
- By:
- Publication type:
- Article
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2841, doi. 10.3390/cancers13112841
- By:
- Publication type:
- Article
Radiotherapy in Follicular Lymphoma Staged by 18 F-FDG-PET/CT: A German Monocenter Study.
- Published in:
- Biomedicines, 2021, v. 9, n. 5, p. 561, doi. 10.3390/biomedicines9050561
- By:
- Publication type:
- Article
Cytokeratin expression in plasmablastic lymphoma – a possible diagnostic pitfall in the routine work‐up of tumours.
- Published in:
- Histopathology, 2021, v. 78, n. 6, p. 831, doi. 10.1111/his.14300
- By:
- Publication type:
- Article
Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e148, doi. 10.1111/bjh.17365
- By:
- Publication type:
- Article
Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 494, doi. 10.1111/bjh.16853
- By:
- Publication type:
- Article
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice